All Articles

Letter to the Editor 
Fibroids through the ages: a historical journey and future prospects in myomectomy
Omer Lutfi Tapisiz, Sadiman Kiykac Altinbas
Gynecology and Pelvic Medicine  
2024;
7:
31  
Editorial Commentary 
Is it time to add BRCA1 promoter methylation testing in the arsenal of ovarian cancer diagnostic tools?
Monica D. Levine, Leigha Senter, David M. O’Malley
Gynecology and Pelvic Medicine  
2024;
7:
30  
Editorial Commentary 
Beyond immunotherapy—treatment advances in cell-based therapy for ovarian cancer and associated challenges
Connie D. Cao, J. Robert McCorkle, Jill M. Kolesar
Gynecology and Pelvic Medicine  
2024;
7:
29  
Case Report 
Uterine tumor with characteristics of ovarian sex-cord tumor: case report
Nicolas Merlim de Oliveira, Maysa Caputo de Oliveira, Bruna de Moura Correa, Iwens Moreira de Faria
Gynecology and Pelvic Medicine  
2024;
7:
28  
Case Report 
Clear-cell borderline tumor with pseudo-Meigs’ syndrome: a case report and review of the literature
David E. Lee, Laura Walters, Barry Rosen
Gynecology and Pelvic Medicine  
2024;
7:
27  
Review Article 
Uterine fibroids & infertility: which fibroids should be removed?—a narrative review
Engin Turkgeldi, Uzeyir Kalkan, Baris Ata
Gynecology and Pelvic Medicine  
2024;
7:
26  
Review Article 
Are there any limits for laparoscopic myomectomy?—tips & tricks
Hale Goksever Celik, Ercan Bastu
Gynecology and Pelvic Medicine  
2024;
7:
25  
Review Article 
Evolution of stress urinary incontinence (SUI) outcomes assessment: a narrative review
Katherine Wu, Emily Huang, Kathleen C. Kobashi
Gynecology and Pelvic Medicine  
2024;
7:
24  
Review Article 
Uterine fibroids: a narrative review of epidemiology and management, with a focus on uterine artery embolization
Mohannad Samy Behairy, Dylan Goldsmith, Collin Schultz, James J. Morrison, Younes Jahangiri
Gynecology and Pelvic Medicine  
2024;
7:
23  
Original Article 
Management and prognosis of uterine sarcoma in elderly
Mikel Gorostidi, Violeta Romero, Yusuf Yildirim, Ronalds Macuks, Rosanna Mancari, Patriciu Achimas-Cadariu, Juan Carlos Muruzabal, Pluvio J. Coronado, Barbara Gardella, Ignacio Zapardiel
Gynecology and Pelvic Medicine  
2024;
7:
22  
Editorial Commentary 
Gynecologic reconstructive surgery: tailoring the postoperative care to the patient
Alberto Cannoni, Francesca Marchetti, Matteo Giorgi, Irene Colombi, Alessandro Ginetti, Francesco Fedele, Francesco Martire, Lucia Lazzeri, Nassir Habib, Errico Zupi, Gabriele Centini
Gynecology and Pelvic Medicine  
2024;
7:
20  
Editorial Commentary 
Polymorphism and pelvic organ prolapse: combining strict inclusion criteria and environmental risk factors as a good standard for further studies
Morgane Le Beulze, Aissatu Balde-Camara, François Vialard
Gynecology and Pelvic Medicine  
2024;
7:
19  
Editorial Commentary 
Commentary on “Age and postoperative opioid use in women undergoing pelvic organ prolapse surgery”
Pranjal Agrawal, Taylor P. Kohn, Jaden Kohn
Gynecology and Pelvic Medicine  
2024;
7:
18  
Editorial Commentary 
Anterior pelvic organ prolapse repair: the intersection of science and art
Patrick Dällenbach
Gynecology and Pelvic Medicine  
2024;
7:
17  
Editorial Commentary 
Pessary-related complications: a brief overview
Marta J. Monist, Beata Dobrowolska, Andrzej Semczuk
Gynecology and Pelvic Medicine  
2024;
7:
16  
Review Article 
Scoping review of evidence-based postoperative recommendations following urogynecology surgery
Rosa Carbonell, Eleanor M. Schmidt, Sara Cichowski
Gynecology and Pelvic Medicine  
2024;
7:
13  
Review Article 
Evaluation and management of urinary incontinence in nursing home residents: unique considerations for an at-risk population
Ioana Marcu, Allison Powell, Lisa C. Hickman
Gynecology and Pelvic Medicine  
2024;
7:
12  
Original Article 
A survey in Liangshan, Sichuan showed higher human papillomavirus infection rate and cervical cancer risk for Yi Chinese compared to Han Chinese
Qingli Li, Yuanqiong Duan, Juan Du, Jinjing Zhang, Shimei Pu, Rong Guo, Ping Song, Qixun Fang, Baoyan Ren, Lianyun Wu, Yue Wang, Lihui Wei, Weiguo Lv, Yan Zuo, Rutie Yin
Gynecology and Pelvic Medicine  
2024;
7:
10  
Editorial Commentary 
Exploring racial and ethnic disparities in cervical cancer’s histologic subtypes
Andréia Cristina de Melo, Sofia Vidaurre Mendes, Jessé Lopes da Silva
Gynecology and Pelvic Medicine  
2024;
7:
9  
Editorial Commentary 
Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer
Walter H. Gotlieb, Yossi Tzur
Gynecology and Pelvic Medicine  
2024;
7:
8  
Editorial Commentary 
Alterations in the MAPK pathway: promising biomarkers for MEK1/2 inhibition
Thaïs Baert, Tine Ottenbourgs, Toon Van Gorp, Els Van Nieuwenhuysen
Gynecology and Pelvic Medicine  
2024;
7:
7